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INTRODUCTION
Reconstructive procedures utilized by plastic surgeons 
often benefit from extra epithelial and supportive tissue 
that can be obtained through tissue expansion techniques. 
Although widely used for skin applications, tissue expansion 
has less of a role in oral and maxillofacial surgery. Expan-
sion of oral mucosa for the surgical grafting of lost alveolar 
bone (vertical ridge augmentation) has been particularly 
challenging because of atrophy following loss of teeth.
Disclosure: Portions of the research reported in this publication 
were supported by the National Institute of General Medical 
Sciences of the National Institutes of Health under Award 
Number R44GM106735. A Cooperative Research and 
Development Agreement (CRADA) existed between Akina, 
Inc. and the Richard L. Roudebush VA Medical Center for 
this study. This material is the result of work supported with 
resources and the use of facilities at the Richard L. Roudebush 
VA Medical Center, Indianapolis, Ind. The content is solely the 
responsibility of the authors and does not necessarily represent 
the official views of the National Institutes of Health, the U.S. 
Department of Veterans Affairs, or the U.S. Government. 
Drs. Barwinska and Davidson, Mr. Cook, Mr. Eckert, and Drs. 
Tholpady and March report no conflicts of interest. Mr. Garner 
and Dr. Park are associated with Akina, Inc., the institution 
developing the Restiex expander. Mr.Garner, Dr. Park, and Dr. 
Barco are listed on a patent application for the hydrogel tissue 
expander studied. The Article Processing Charge was sponsored 
by the Indiana Institute for Medical Research.
Mucosal Perfusion Preservation by a Novel 
Shapeable Tissue Expander for Oral Reconstruction
From the *Department of Cellular and Integrative Physiology, 
Indiana University, Indianapolis, Ind. †Indiana Center for Vascular 
Biology and Medicine, Indiana University, Indianapolis, Ind.; 
‡VC-CAST Signature Center, Indiana University, Indianapolis, 
Ind.; §Regenerative Medicine Division, Roudebush Veteran Affairs 
Medical Center, Indianapolis, Ind.; ¶Akina, Inc. West Lafayette, 
Ind.; ‖Department of Pathology and Laboratory Medicine, Indiana 
University, Indianapolis, Ind.; **Department of Biostatistics, 
Indiana University, Indianapolis, Ind.; ††Plastic Surgery Division, 
Roudebush Veteran Affairs Medical Center, Indianapolis, Ind.; 
‡‡Division of Cardiology, Department of Medicine, Indiana 
University, Indianapolis, Ind.; §§Department of Biomedical 
Engineering, Purdue University, West Lafayette, Ind.; ¶¶Roudebush 
Veterans Affairs Medical Center, Dental Service, Indianapolis, Ind.
Received for publication April 1, 2017; accepted June 27, 2017.
Copyright © 2017 The Authors. Published by Wolters Kluwer Health, 
Inc. on behalf of The American Society of Plastic Surgeons. This is 
an open-access article distributed under the terms of the Creative 
Commons Attribution-Non Commercial-No Derivatives License 4.0 
(CCBY-NC-ND), where it is permissible to download and share the 
work provided it is properly cited. The work cannot be changed in 




Darrell D. Davidson, MD, PhD‖
Todd G. Cook, AAS†
George J. Eckert, MAS**
Sunil S. Tholpady, MD, PhD††
Keith L. March, MD, PhD*†‡§‡‡
Kinam Park, PhD¶§§
Clark T. Barco, DDS, MS¶¶
Barwinska et al.
Background: There are few methods for expanding oral mucosa, and these often 
cause complications such as tissue necrosis and expander eruption. This study ex-
amines mucosal blood perfusion following insertion of a novel shapeable hydro-
gel tissue expander (HTE). The canine model used subgingival insertion of HTE 
following tooth extraction and alveolar bone reduction. The primary goal of this 
study was to gain understanding of epithelial perfusion and reparative responses of 
gingival mucosa during HTE expansion.
Methods: Nine Beagle dogs underwent bilateral premolar maxillary and mandibular 
tooth extraction. Three to four months later, HTE-contoured inserts were implanted 
submucosally under the buccal surface of the alveolar ridge. After removal and follow-
ing a 6- to 7-month period of healing, new HTE implants were inserted at the same 
sites. The area was assessed weekly for tissue perfusion and volume of expansion. 
Biopsies for histological analysis were performed at the time of expander removal.
Results: Within 2 weeks following the second insertion, blood flow returned to 
baseline (defined as the values of perfusion measurements at the presurgery assess-
ment) and remained normal until hydrogel full expansion and removal. Volume 
expansion analysis revealed that the hydrogel doubled in volume. Histological as-
sessment showed no macrophage or inflammatory infiltration of the mucosa. No 
superficial fibrosis, decreased vascularity, or mucosal change was seen.
Conclusion: Maintenance of adequate tissue perfusion is a clinically important aspect 
of tissue expander performance to reduce risk of device loss or injury to the patient, 
particularly for areas with a history of previous surgeries. (Plast Reconstr Surg Glob Open 
2017;5:e1449; doi: 10.1097/GOX.0000000000001449; Published online 28 August 2017.)
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Similarly, challenges have been reported in expand-
ing oral mucosa for cleft palate reconstruction, where 
alveolar bone grafting is a key part of the procedure.1 
Current practice to cover a bone graft relies on a ten-
sion-free mucosa coverage that involves superficial split-
thickness flap and a pedicle flap. Many variations of 
these techniques have been developed2,3 though reduc-
tion of perfusion in the flaps has been shown.4,5 Oral 
mucosa stretched over a bone graft can necrose because 
of poor vascularization, exposing the vulnerable bone 
graft and putting it in contact with microbes of the oral 
cavity.6,7 Exposure of the bone grafts for vertical ridge 
augmentation, as shown in Figure 1, is a major cause of 
prerestorative complications that range from significant 
volume reduction in the final healing stages to complete 
loss of the bone graft.6,8–15 Osmotically controlled hydro-
gel tissue expanders (HTEs) have been shown to offer 
a promising new method,16 applicable both for skin17–20 
and oral mucosa (for the purpose of bone grafting).7,21 
However, rapid expansion of an HTE can lead to isch-
emia and subsequent necrosis of the expanding skin or 
oral mucosa, leading to loss of the device and exposure 
of alveolar bone.
21,22
The optimal HTE would be easily inserted, readily 
altered to the shape and size needed, and designed to 
expand at a rate that allows constant blood perfusion to 
the mucosal flap.22 Hydrogel devices are inserted beneath 
closed mucosa and expand gradually by reaction with 
moisture from the surrounding stroma. Controlling the 
mechanical properties of speed and expansion pressure 
is essential for preserving tissue perfusion while promot-
ing adequate expansion. In this study, a novel osmotic 
HTE with optimized expansion properties was evaluated 
for movement, volume change, and mechanical strength 
of the device, as well as for perfusion in the expanding 
mucosa. Perfusion effects and device failure rates were 
studied in the canine model assessing risks for clinical ap-
plications.
METHODS
Canine Model of Tissue Expansion
The study was approved by the Indiana University In-
stitutional Animal Care and Use Committee. Nine female 
Beagle dogs (Marshall BioResources, North Rose, N.Y.) 
aged 13 months were used. The animal model of mucosa 
undergoing surgical manipulation following loss of teeth 
was created via bilateral extraction of premolar maxillary 
and mandibular teeth from each dog (a total of 14 teeth). 
After 3 months, an initial set of HTEs was placed in each of 
the 4 extraction sites for each dog, via full-thickness flap, 
using a single curved vertical incision. The 4 sites were in 
the right and left maxilla, and right and left mandible in 
the buccal mucosa adjacent to the dental extraction sites. 
The HTEs were removed on day 42 postinsertion. The dogs 
were allowed to recover for 3 months, and at this point, the 
model was considered to be established. A set of HTEs was 
placed again within the previously surgically manipulated 
oral mucosa sites, for a period of 42 days. Blood perfusion 
in the oral mucosa and expander volume were evaluated at 
each of the extraction sites in each dog immediately before 
and after the HTE insertion. The insertions were evaluated 
once a week for 6 weeks. Full-thickness mucosa and soft-
tissue biopsies were collected from 7 predetermined loca-
tions for each insertion site (Fig. 2).
Osmotic HTE Fabrication
The Restiex HTE (Akina, Inc., West Lafayette, Ind.) 
was used in the study. The manufactured hydrogels were 
sterilized by ethylene oxide (Andersen Sterilizer) and 
aseptically handled before use in surgery.
Fig. 1.  alveolar bone graft examples with fenestration (patient 1: a and B) and dehiscence (patient 2: C, D, and E). a, Significant alveolar 
bone defect from trauma. B, Fenestration first appeared 5 months after bone grafting (black arrow). C, Bone graft for a “vertical ridge 
augmentation,” left posterior mandible. a significant facial split-thickness flap was done to cover the bone graft. note the blanching of 
the mucosa along the incision line. D, Dehiscence at the incision site 13 days following bone grafting. E, panoramic radiograph of bone 
resorption on the left as compared with the right side; the radiograph was taken after the failed bone graft.
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Laser Speckle Contrast Imager Assessment of In Vivo 
Tissues
The blood flow at each insertion site was analyzed for 
a period of 1 minute using full-field, 780 nm Class 1 Laser 
Speckle Contrast Imager (LSI; FLPI, MOOR Inc., United 
Kingdom) at the low resolution/high-speed image acquisi-
tion rate of 25 Hz. The penetration depth of LSI in these 
measurements is approximately 1 mm. For each set of 
measurements, the 4 insertion sites were imaged using 2 
regions of interest (ROIs) for each scan. At each insertion 
site, ROI-1 represents the area of mucosa directly overlying 
the hydrogel and ROI-2 encompasses a nearby surgically 
untouched mucosal area (control).
Assessment of Hydrogel Movement and Volume Expansion
FaroArm (FARO Technologies, Lake Mary, Fla.) laser 
surface scan (660 nm V2 laser probe, Class 2M) was used to 
obtain a 3-dimensional analysis and dynamics of hydrogel 
movement within the oral mucosa for 6 of the 9 dogs un-
dergoing the procedure. Each scan was analyzed in chron-
ological sequence to provide a graphic representation of 
the location of the expanding hydrogel. Any movement of 
the hydrogel during expansion was determined by the dis-
tance between the expander and a static point, usually the 
adjacent canine tooth.
Each HTE was photographed using a Nikon D90 cam-
era (Nikon Corporation, Shinagawa, Tokyo, Japan) with a 
Nikon AF-S VR Micro-Nikkor 105 mm f/2.8G IF-ED lens, 
just before insertion and immediately after full expansion 
and removal. A ruler was placed in the frame of the photo-
graph for calibration purposes. The camera was mounted 
on a stand positioned 50 cm away from the specimen. The 
images were analyzed using Olympus Microsuite 5 software 
and the dimensional change in width was determined.
Ultrasound images were obtained from the insertion 
sites of 3 dogs, using Vevo 2100 System (VisualSonics, Toron-
to, Canada). A MicroScan Transducer LK (40 MHz frequen-
cy) was used to scan the implant using B-mode to collect 
short and long axis views. The change in HTE volume was 
assessed by measuring their length, height, and width to es-
timate the volume at weekly time points during expansion.
Histologic Analysis
Immediately after hydrogel removal on day 42, 2.0-mm 
circular punch biopsies were taken through the anterior 
(rostral) and posterior (caudal) mucosal zones of the ex-
pansion site and into the periosteum at the deepest internal 
extent of the HTE (Fig. 2). The paraffin-embedded biopsies 
were oriented in each block so that 4-micron sections of the 
cylinders included both superficial and deep tissues. Histo-
logic sections were stained with hematoxylin and eosin and 
with Masson’s trichrome stain. Each section was graded for 
vascularity of the mucosal flap, extent of histiocytic infiltra-
tion near the gel, and thickness of the fibrous capsule. Each 
section was also examined for the presence of any retained 
hydrogel, chronic inflammatory cells, acute inflammatory 
cells, and proper orientation of the biopsy core to permit 
full-thickness evaluation. Hematoxylin and eosin stained 
slides were used to detect inflammatory cell infiltration and 
to identify the cell types involved.
Statistical Analysis
Mixed-model analysis of variance tests were performed 
to compare LSI relative perfusion in the HTE flaps at dif-
ferent insertion sites and at weekly intervals. Analysis of 
variance comparisons were also made over time and be-
tween different insertion sites within each dog. A signifi-
cance level of 5% was used for all tests. Standard error of 
the mean values are represented in the graphs.
RESULTS
HTE Volume and Movement Assessment
FaroArm surface contour scanning (images not shown), 
revealed little to no movement of the expanding HTE, espe-
cially after the first 2 weeks postinsertion. The average dis-
tance of HTE shift was 2.7 mm. The analysis of the images 
showed a consistent linear expansion of 32%, which trans-
lated to 107% gain of oral mucosa linear dimension. The 
mandibular sites showed a slightly greater volume increase 
(21.5 mm3) than the maxillary sites, although the difference 
is not statistically significant (images not shown). The ultra-
sound data revealed a steady volume increase of 3.5% per 
day. The sonographic images of HTE implants showed a uni-
form hypoechoic zone with clearly defined borders that in-
creased in size over the expansion period (Fig. 3). Similarly, 
Figure 3D shows the side-by-side comparison of HTE devices 
before insertion and after 6 weeks of expansion. None of the 
expanded HTE implants crumbled during removal. Only 
5 implants were slightly fragmented (4 broke into 2 large 
pieces), and the rest was removed as a whole.
Tissue Perfusion Assessment in Oral Mucosa
The LSI blood flow assessment compared the perfu-
sion of the area directly overlying the tissue expander with 
an area of nonoperated gingival mucosa nearby (control) 
(Fig. 4). Within the first 2 weeks, this perfusion ratio some-
times showed slight hypo- or hyperperfusion, although 
not in every case. The slight initial increase in perfusion 
may represent vasodilation from postoperative inflamma-
tion. Slightly decreased initial perfusion may represent 
Fig. 2. Biopsy sites. Seven punch biopsies were obtained, through 
the anterior (rostral) and posterior (caudal) mucosal zones of the 
expansion site, and into the periosteum. a 2.0-mm circular punch 
biopsy knife was used.
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Fig. 3. Qualitative assessment of expanded tissue overlaying the hydrogel using ultrasound 
analysis of HtE volume change revealed volume doubling at a rate of 3.5% per day. a and B, 
representative images of the same hydrogel pellet on days 8 and 45. the echogenic bright 
lines at the bottom of image represent the periosteum, and the echolucent dark zones are 
hydrogel. C, Change in volume expansion of the hydrogel for maxillary and mandibular sites 
in 3 dogs. D, image showing the hydrogel before the insertion (bottom) and immediately af-
ter removal, after 6 weeks of tissue expansion (top). physical condition of the expanded HtEs 
was judged as “whole,” “fragmented,” or “crumbled.”
Fig. 4. Quantitative laser speckle contrast imaging assessment of blood perfusion in the superficial layers of oral mucosa overlying the hydro-
gel compared with the control site indicates sufficient tissue perfusion maintained following the first 2 weeks after tissue expander insertion. 
the lSi technique uses the dynamic optical speckle of a low intensity laser shining on the mucosa to quantitatively measure microvascular 
blood flow. a and B, Flux (laser illuminated) and photographic (white light illuminated) images rendered by the laser speckle contrast imager in 
maxilla. arrows mark outlined rOi: hydrogel and control site for comparison. C, Comparisons of weekly mean blood perfusion values expressed 
as the ratio of hydrogel and control rOi flux. D and E, Comparisons of weekly mean blood perfusion values for mandibular and maxillary sites.
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stretching of the vessels before local vasomotor accommo-
dation. After approximately 2 weeks, however, the blood 
flow ratio returned to a level congruent with the baseline 
ratio of that area before expander insertion. There were 
no clinical changes in the expanded area of mucosa such 
as erythema, blanching, edema, or necrosis.
Histological Assessment of the Oral Mucosa Biopsies
For each HTE site, a total of 7 biopsies were obtained 
(Fig. 2). Each soft-tissue biopsy was stained with hematoxy-
lin and eosin and with Masson’s trichrome stain. The tissue 
samples around the HTE implant showed no infiltration by 
chronic or acute inflammatory cells, minimal dense fibrosis, 
and minimal retained microscopic hydrogel particles after 
the expander removal (a thin, uniform fibrous capsule sur-
rounding the expanded HTE was grossly observed at the time 
of removal). Evaluation of these parameters was confirmed 
by comparison of HTE-related biopsies with control biop-
sies from nearby unoperated mucosa. Importantly, a slight 
increase in the vascular density of the tissue flaps was seen in 
biopsies adjacent to HTE on day 42, suggesting that neovas-
cularization had taken place. This assessment compared the 
mucosal vascular density in 2 expanded flap sites (rostral and 
caudal) with the vascular density at 2 control sites (rostral 
and caudal). The average vascular density for control sites 
varied from spare to focally dense, whereas in the areas asso-
ciated with the expander vascular density, it ranged from fo-
cally dense to diffuse dense neovascularity. No difference in 
vascularity was observed between maxillary and mandibular 
sites (Fig. 5A). No other changes were detected by histologic 
examination (Fig. 5B, C).
DISCUSSION
Bone grafting in oral mucosa is a challenging clinical 
problem because increased bone volume must be accom-
panied by increased mucosa to allow engraftment and 
healing of the new graft. Vascular deficiency within soft 
tissue or mucosal flap tension pose risk of bone graft expo-
sure.4–6 Even slight exposure markedly decreases engraft-
ment of the new bone and creates a need for secondary 
procedures to manage the complications.6
Oral mucosa expansion can be a useful technique for 
palate reconstructions, extirpation of benign oral lesions, 
and bone grafting to replace resorbed alveolar ridge. Rapid 
tissue expansion, however, may cause epithelial necrosis as 
well as discomfort, expander migration, hematoma, infec-
tion, and wound dehiscence.22 Current surgical techniques 
for covering bone graft with mucosa result in decreased 
perfusion in the surgically elevated flaps.4,5 Figure 1A, B 
demonstrated a soft-tissue fenestration that first appeared 
5 months after a split-thickness flap was placed over a bone 
graft. Based on the findings presented by Kaner et al.,23 we 
believe that reduced blood perfusion in the oral mucosa 
covering bone grafts is associated with decreased bone oxy-
genation, reduction of the volume and quality of the bone 
graft, and overall decline of the healing process.24
More tools are needed that address the concerns of 
safe and effective tissue expansion.
Self-expanding HTE devices are an attractive alterna-
tive to the use of silicone “balloons,” which are commonly 
utilized in plastic surgery. Osmotic devices, carefully for-
mulated to achieve the proper rate and final volume of 
expansion, are designed for full implantation without 
the presence of exposed tubes or ports. HTE for use in 
oral mucosa before a bone graft has shown significantly 
improved outcomes in dogs24 and humans,21 when com-
pared with the traditional split-thickness advancement of 
the oral mucosa over bone grafts.
Currently HTEs being developed for human use by 
Oxtex Ltd and OsmedGmbH are enveloped in a silicone 
capsule that prevents the surgeon from reshaping and re-
sizing the expander. HTEs developed by Oxtex Ltd have 
been shown to successfully expand palate oral mucosa in 
pigs.25 HTEs developed by OsmedGmbH, which use a screw 
to secure it in the desired position, were reported to erupt 
during oral mucosa expansion in 17%21 and 27%7 of cases 
in human subjects. Nevertheless, it is encouraging that 
Kaner and Friedmann21 reported mean vertical bone gain 
Fig. 5.  Histological assessment of the oral mucosa at the time of tissue expander removal indicates no concerning pathological changes, 
fibrosis, or inflammation, and satisfactory vascularity for both first and second insertions. a, Biopsies from the expander sites (OC, Or) and 
nonexpander sites (C2, r2) were assessed for vascular density. Score 0 indicated absence of vessels; score 1, scattered small vessels seen 
mainly at high power (sparse); score 2, frequent small vessels, mainly capillaries (dense); and score 3, many variable sized vessels includ-
ing large thin-wall neovascularity usually associated with granulation tissue (very dense; **P = 0.029, ***P = 0.007). B and C, Histological 
assessment of tissue in the same dog, mandible, (B, hematoxylin and eosin; C, trichrome).
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of 7.5 ± 2.4 mm in 12 patients using HTEs before bone 
grafting.
The Restiex HTE in the current study causes slow, 
steady expansion of oral mucosa with only a 3% incidence 
of device extrusion. Additionally, the lack of a silicone 
shell allows the expander to be cut to a desired size at the 
time of insertion (Fig. 6A).
The availability of HTEs that allows a more personalized 
approach to tissue expansion and being aware that adequate 
blood perfusion is critical for preventing tissue necrosis26 has 
resulted in a hypothesis that gradual tissue expansion by a 
fully implanted device would preserve mucosal perfusion 
and reduce extrusion of the expanding HTE. Both the rate 
and final volume of Restiex® HTEs can be adjusted by al-
tering the components in the polymerization formulation. 
To mimic frequent clinical settings where a bone is grafted 
in a location with a history of trauma and past surgical pro-
cedures, this study used a canine model in which a preex-
isting scar tissue from a previous expansion was developed. 
The evaluation of HTE performance in tissues previously 
exposed to surgery, which reflects a common occurrence in 
medical practice, will allow for collection of data that repre-
sent the more clinically relevant and challenging scenarios. 
The main focus of this study is to assess tissue perfusion of 
expanding oral tissue, particularly since the importance of 
slight perfusion changes in the mucosa may be underesti-
mated because of the normal rich oversupply of blood ves-
sels in these tissues. To assess the perfusion of oral mucosa, 
we employed an LSI to record the average perfusion of the 
entire area of expanding tissue to a depth of 1 mm. The LSI 
overcomes the limitations of other mucosal perfusion mea-
surement techniques to combine both high spatial accuracy 
in ROI and high temporal resolution of changes over a wide 
range of time intervals. The LSI assessment of blood flow in 
the superficial mucosa over the HTE revealed no circulatory 
compromise relative to adjacent unexpanded mucosa. The 
histological assessment revealed no pathological findings 
and no inflammatory responses. The biopsies showed an in-
crease in the vessel density as other investigators have noted 
in expanded skin.27 Moreover, the Restiex HTE doubled in 
volume size and retained its shape and uniform structure 
throughout the expansion. At the same time, we observed 
little to no migration of the device. Most likely a thin fibrous 
capsule that formed within 1 week had secured the hydrogel 
in position.28 To establish the animal model of previous tissue 
manipulation, we have subjected dogs to initial tissue expan-
sion, with associated fibrous capsule formation. Although 
the capsule presence was not observed after the 3 months 
of healing time during the insertion of our tested HTEs and 
had likely undergone full resorption, we do acknowledge 
that the effect of a previously present capsule on the vascu-
lature is not known. In addition, our histology data showed 
little to no vascularity within the fibrous capsule region.
Although histological changes occur in all tissues fol-
lowing surgical procedures, changes in oral mucosa are 
less pronounced, though it continues to exhibit altered 
morphology, following surgery or trauma.29,30
HTEs offer the significant advantage of self-expansion, 
reducing the frequency of appointments, discomfort, and 
risk of infection associated with silicone balloon inflation. 
Because self-inflating tissue expanders cannot be con-
trolled during expansion, HTEs must have precise physical 
Fig. 6. restiex HtE used in the study; illustration of tissue expander placement in the mandible. a, the dimensions of the HtE used in the 
study can be adjusted based on the desired size of the skin or mucosal flap to be generated. B, the HtE is comprised of a combination 
of hydrophilic polyethers and hydrophobic polyethers crosslinked by acrylate linkages. the hydrophobic polyesters are hydrolytically 
unstable and spontaneously degrade upon exposure to water in the warm, slightly alkaline environment of tissue interstices. as these 
portions are cleaved, the crosslinking density and overall hydrophobicity of the expander decrease, allowing the HtE to swell to a larger 
size over time. this mechanism causes the expander as a whole to swell at a slow, controlled rate over the course of 1–6 weeks.
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characteristics (e.g., delay, force, rate, and volume of swell-
ing) for the anatomic area of interest (e.g., mouth, nose, 
breast) to achieve optimal results and ensure patient safe-
ty.22,31 Although this study explored a novel Restiex HTE 
for use in dental reconstructions in our dog study and as 
illustrated for human use in Figure 6B, a similar HTE has 
shown remarkable results in closing 19 cleft palates in chil-
dren.32 Investigation of Restiex HTE for other applications 
requiring epithelial expansion may be warranted.
In conclusion, we found that gradual tissue expansion 
with a volume increase of 3.5% per day allows mainte-
nance of normal vascularization and perfusion in canine 
oral mucosa.
Adequate blood circulation, avoidance of postopera-
tive trauma to the site, and elimination of the possibility 
of infection are necessary to ensure the expander remains 
in place and does not cause injury to the patient. The Res-
tiex HTE preserved mucosal flap perfusion throughout 
the expansion phase and offered unique qualities such as 
minimal tissue reaction to the device and the ability to be 
shaped by the surgeon. This animal study indicates that a 
shapeable HTE may be an attractive device for various tis-
sue expansion purposes in humans.
Clark T. Barco, DDS, MS
Roudebush VA Medical Center
Dental Service (160)
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